Replies to post #261519 on Amarin Corp Plc (AMRN)

[oneragman]

Raf, that's why I prefaced it as OT(out there). Think of this though. Best Buy sells movies in their store. They come from Disney, Paramount, etc. If they start selling knockoffs, they are breaking the law. If they are used beyond the liscense, like copied and resold in a unauthorized territory, that could be a problem. Now if the feds don't get involved, they will be sued for distributing knockoffs or breaking the licensing agreement. So the out there question is, could AMRN make a case that whether a doctor or pharmacy are not diligent in prescribing the appropriate medication for the appropriate indication, it amounts to intellectual property theft.
So theft is the prescription for CV risk reduction when the patient doesn't have tg's over 500. The generics get 500 and over...that it. There's new law all the time. Long week and I know it's out there, but why is that not the case? Not practical for a doctor...sure. What about a pharmacy or hospital group though.

[HinduKush]

If a physician prescribed a generic EPA ( or a pharmacist substituted it without specific MD permission) instead of Vascepa “off label” after a vascular event and lets say the patient upped and died the next month of an MI, the physician could be sued for malpractice on the basis of using a non-approved drug off label dangerously when there was a perfectly good FDA-approved RI INDICATION to use Vascepa. I believe the case would not be defensible and whether the insurance approved or allowed generic EPA would hold no water....